Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751061 | 12675106 | 1 | I | 20160809 | 20160823 | 20160823 | EXP | US-TEVA-686654USA | TEVA | GOLOMB BA, KOSLIK HJ, REDD AJ. FLUOROQUINOLONE-INDUCED SERIOUS, PERSISTENT, MULTISYMPTOM ADVERSE EFFECTS.BMJ CASE REPORTS. 2015:ARTICLE NUMBER 209821 | 46.00 | YR | M | Y | 0.00000 | 20160823 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751061 | 12675106 | 1 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | N | 76361 | 750 | MG | ||||||||
| 126751061 | 12675106 | 2 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | 0 | 10 | MG | QD | |||||||||
| 126751061 | 12675106 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | 30 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126751061 | 12675106 | 1 | Epididymitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126751061 | 12675106 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126751061 | 12675106 | Affective disorder | |
| 126751061 | 12675106 | Atrophy | |
| 126751061 | 12675106 | Bradycardia | |
| 126751061 | 12675106 | Cognitive disorder | |
| 126751061 | 12675106 | Eye disorder | |
| 126751061 | 12675106 | Fatigue | |
| 126751061 | 12675106 | Fibromyalgia | |
| 126751061 | 12675106 | Gastrointestinal disorder | |
| 126751061 | 12675106 | Gastrointestinal motility disorder | |
| 126751061 | 12675106 | Muscular weakness | |
| 126751061 | 12675106 | Polyneuropathy | |
| 126751061 | 12675106 | Respiratory muscle weakness | |
| 126751061 | 12675106 | Tachycardia | |
| 126751061 | 12675106 | Tendon disorder | |
| 126751061 | 12675106 | Toxicity to various agents | |
| 126751061 | 12675106 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |